España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Revvity
RVTY
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$124.06
0.91
0.74%
At close: -
$124.06
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Q4 2024 Earnings in 4 days from now on Fri Jan 31st, before the market open
Conference call scheduled in 4 days at 8:00 AM
Click to view the webcast
Revvity (RVTY) Forecast
News
Earnings
Revvity (RVTY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Revvity (NYSE:RVTY) Stock
Revvity Stock (NYSE: RVTY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 22, 2025
(RVTY) - Analyzing Revvity's Short Interest
Benzinga Insights
Tuesday, January 21, 2025
Forecasting The Future: 7 Analyst Projections For Revvity
Benzinga Insights
Raymond James Maintains Outperform on Revvity...
Benzinga Newsdesk
Monday, January 13, 2025
Revvity shares are trading higher after the c...
Benzinga Newsdesk
Revvity Partners with Element Biosciences to ...
Benzinga Newsdesk
Friday, January 10, 2025
Revvity Receives FDA Clearance For EUROIMMUN'...
Benzinga Newsdesk
Friday, December 13, 2024
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst
Vandana Singh
B of A Securities Upgrades Revvity to Buy, An...
Benzinga Newsdesk
Monday, November 25, 2024
Barclays Maintains Overweight on Revvity, Low...
Benzinga Newsdesk
Wednesday, November 20, 2024
Revvity Announces An Expansion Of Its Work Wi...
Benzinga Newsdesk
Tuesday, November 19, 2024
Scale Biosciences And Revvity's BioLegend Lau...
Benzinga Newsdesk
Monday, November 18, 2024
Revvity Announces Investor Day For Nov. 21 An...
Benzinga Newsdesk
Tuesday, November 05, 2024
These Analysts Revise Their Forecasts On Revvity Following Q3 Results
Avi Kapoor
TD Cowen Maintains Buy on Revvity, Raises Pri...
Benzinga Newsdesk
Bernstein Maintains Outperform on Revvity, Lo...
Benzinga Newsdesk
Raymond James Maintains Outperform on Revvity...
Benzinga Newsdesk
Baird Maintains Outperform on Revvity, Raises...
Benzinga Newsdesk
Monday, November 04, 2024
Revvity Authorizes New $1B Share Repurchase P...
Benzinga Newsdesk
Revvity Q3 2024 Adj EPS $1.28 Beats $1.13 Est...
Benzinga Newsdesk
Tuesday, October 15, 2024
Assessing Revvity: Insights From 8 Financial Analysts
Benzinga Insights
Barclays Upgrades Revvity to Overweight, Rais...
Benzinga Newsdesk
Tuesday, September 10, 2024
Looking Into Revvity's Recent Short Interest
Benzinga Insights
Tuesday, August 27, 2024
Wells Fargo Initiates Coverage On Revvity wit...
Benzinga Newsdesk
Tuesday, July 30, 2024
TD Cowen Maintains Buy on Revvity, Raises Pri...
Benzinga Newsdesk
Citigroup Maintains Buy on Revvity, Raises Pr...
Benzinga Newsdesk
JP Morgan Maintains Neutral on Revvity, Raise...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on Revvity, R...
Benzinga Newsdesk
B of A Securities Maintains Neutral on Revvit...
Benzinga Newsdesk
Monday, July 29, 2024
Jefferies Maintains Hold on Revvity, Raises P...
Benzinga Newsdesk
Wall Street Rises Ahead Of Big Tech Earnings, Fed Meeting; Tesla Rebounds, Oil Prices Drop To 7-Week Lows: What's Driving Markets Monday?
Piero Cingari
Life Science Firm Revvity Lifts Annual Profit Forecast On Strong Q2 Performance
Vandana Singh
Revvity shares are trading higher after the c...
Benzinga Newsdesk
Revvity Updates Its 2024 Adjusted EPS Guidanc...
Benzinga Newsdesk
Revvity Updates Its 2024 Sales Guidance To $2...
Benzinga Newsdesk
Revvity Q2 2024 Adj EPS $1.22 Beats $1.12 Est...
Benzinga Newsdesk
Monday, July 08, 2024
Leerink Partners Initiates Coverage On Revvit...
Benzinga Newsdesk
Wednesday, July 03, 2024
Reasons to Retain Revvity Stock in Your Portfolio Now
Zacks
Friday, June 28, 2024
Barclays Maintains Equal-Weight on Revvity, L...
Benzinga Newsdesk
Tuesday, April 30, 2024
Baird Maintains Outperform on Revvity, Raises...
Benzinga Newsdesk
4 Analysts Have This To Say About Revvity
Benzinga Insights
TD Cowen Maintains Buy on Revvity, Raises Pri...
Benzinga Newsdesk
Monday, April 29, 2024
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?
Piero Cingari
Revvity shares are trading higher after the c...
Benzinga Newsdesk
Revvity Reaffirms Its 2024 Adjusted EPS Guida...
Benzinga Newsdesk
Revvity Revises 2024 Revenue Forecast To $2.7...
Benzinga Newsdesk
Revvity Q1 2024 Adj EPS $0.98 Beats $0.93 Est...
Benzinga Newsdesk
Wednesday, April 24, 2024
Revvity Announced The Launch Of The Auto-pure...
Benzinga Newsdesk
Enphase Energy Reports Weak Results, Joins Lithia Motors And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Monday, April 15, 2024
Revvity To Launch Signals Synergy, Software S...
Benzinga Newsdesk
Tuesday, April 02, 2024
Massachusetts Superior Court Has Granted A Pr...
Benzinga Newsdesk
Show More